STAT News (17 November 2023) reports on the biotech rush to build obesity drugs that protect muscle while cutting fat - an approach inspired by myostatin research and the double-muscled animals it produced. The piece lays out why lean-mass loss on GLP-1 medicines became the industry's next competitive frontier.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.